|Bid||27.77 x 0|
|Ask||27.77 x 0|
|Day's range||27.52 - 28.08|
|52-week range||24.64 - 35.94|
|Beta (5Y monthly)||0.63|
|PE ratio (TTM)||16.27|
|Forward dividend & yield||1.29 (4.63%)|
|Ex-dividend date||28 Jan 2021|
|1y target est||N/A|
J&J's vaccine recommended for emergency use authorization by independent experts. FDA will make a decision this weekend.Johnson & Johnson's (JNJ) single-dose COVID-19 vaccine is one step closer to emergency use authorization (EAU) after an independent panel voted Friday to recommend the U.S. Food and Drug Administration (FDA) issue the EUA.
Pfizer shares are trying to settle below $33.54.
Sanofi (SNY) & Glaxo (GSK) start phase II study on their COVID-19 vaccine candidate. Merck (MRK) offers to buy Pandion Therapeutics for $1.85 billion